nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HTR2A—pancreatitis	0.507	1	CbGaD
Mirtazapine—Left ventricular failure—Hyoscyamine—pancreatitis	0.0164	0.061	CcSEcCtD
Mirtazapine—Angle closure glaucoma—Hyoscyamine—pancreatitis	0.01	0.0372	CcSEcCtD
Mirtazapine—Atrial arrhythmia—Hyoscyamine—pancreatitis	0.00971	0.0361	CcSEcCtD
Mirtazapine—Accommodation disorder—Propantheline—pancreatitis	0.00917	0.034	CcSEcCtD
Mirtazapine—Arrhythmia supraventricular—Hyoscyamine—pancreatitis	0.00695	0.0258	CcSEcCtD
Mirtazapine—Retrosternal pain—Hyoscyamine—pancreatitis	0.00669	0.0248	CcSEcCtD
Mirtazapine—Intraocular pressure increased—Hyoscyamine—pancreatitis	0.00613	0.0228	CcSEcCtD
Mirtazapine—Hyperreflexia—Hyoscyamine—pancreatitis	0.00584	0.0217	CcSEcCtD
Mirtazapine—Salivary hypersecretion—Propantheline—pancreatitis	0.00511	0.019	CcSEcCtD
Mirtazapine—Accommodation disorder—Hyoscyamine—pancreatitis	0.00469	0.0174	CcSEcCtD
Mirtazapine—Blepharitis—Hyoscyamine—pancreatitis	0.00438	0.0163	CcSEcCtD
Mirtazapine—Keratitis—Hyoscyamine—pancreatitis	0.00416	0.0154	CcSEcCtD
Mirtazapine—Thirst—Propantheline—pancreatitis	0.00402	0.0149	CcSEcCtD
Mirtazapine—Paranoia—Hyoscyamine—pancreatitis	0.00395	0.0147	CcSEcCtD
Mirtazapine—Paralysis—Hyoscyamine—pancreatitis	0.00388	0.0144	CcSEcCtD
Mirtazapine—Laryngitis—Hyoscyamine—pancreatitis	0.00374	0.0139	CcSEcCtD
Mirtazapine—Mania—Hyoscyamine—pancreatitis	0.00371	0.0138	CcSEcCtD
Mirtazapine—Ventricular arrhythmia—Hyoscyamine—pancreatitis	0.00364	0.0135	CcSEcCtD
Mirtazapine—Stupor—Hyoscyamine—pancreatitis	0.00361	0.0134	CcSEcCtD
Mirtazapine—Stinging—Hyoscyamine—pancreatitis	0.00333	0.0124	CcSEcCtD
Mirtazapine—Ageusia—Hyoscyamine—pancreatitis	0.00333	0.0124	CcSEcCtD
Mirtazapine—Abdominal distension—Propantheline—pancreatitis	0.00333	0.0123	CcSEcCtD
Mirtazapine—Petechiae—Hyoscyamine—pancreatitis	0.00328	0.0122	CcSEcCtD
Mirtazapine—Extrasystoles—Hyoscyamine—pancreatitis	0.0032	0.0119	CcSEcCtD
Mirtazapine—Delirium—Hyoscyamine—pancreatitis	0.00313	0.0116	CcSEcCtD
Mirtazapine—Erectile dysfunction—Propantheline—pancreatitis	0.00304	0.0113	CcSEcCtD
Mirtazapine—Ventricular extrasystoles—Hyoscyamine—pancreatitis	0.00298	0.0111	CcSEcCtD
Mirtazapine—Drowsiness—Propantheline—pancreatitis	0.00295	0.0109	CcSEcCtD
Mirtazapine—Dysarthria—Hyoscyamine—pancreatitis	0.00285	0.0106	CcSEcCtD
Mirtazapine—Muscle twitching—Hyoscyamine—pancreatitis	0.00275	0.0102	CcSEcCtD
Mirtazapine—Depressed level of consciousness—Hyoscyamine—pancreatitis	0.0026	0.00966	CcSEcCtD
Mirtazapine—Coma—Hyoscyamine—pancreatitis	0.00246	0.00914	CcSEcCtD
Mirtazapine—Pulmonary oedema—Hyoscyamine—pancreatitis	0.0024	0.00891	CcSEcCtD
Mirtazapine—Hypertonia—Hyoscyamine—pancreatitis	0.00236	0.00877	CcSEcCtD
Mirtazapine—Hyperkinesia—Hyoscyamine—pancreatitis	0.00235	0.00873	CcSEcCtD
Mirtazapine—Tension—Propantheline—pancreatitis	0.00226	0.00839	CcSEcCtD
Mirtazapine—Nervousness—Propantheline—pancreatitis	0.00224	0.0083	CcSEcCtD
Mirtazapine—Disorientation—Hyoscyamine—pancreatitis	0.00219	0.00812	CcSEcCtD
Mirtazapine—Eye pain—Hyoscyamine—pancreatitis	0.00217	0.00805	CcSEcCtD
Mirtazapine—Amnesia—Hyoscyamine—pancreatitis	0.00208	0.00773	CcSEcCtD
Mirtazapine—Thirst—Hyoscyamine—pancreatitis	0.00206	0.00763	CcSEcCtD
Mirtazapine—Palpitations—Propantheline—pancreatitis	0.00203	0.00755	CcSEcCtD
Mirtazapine—Lethargy—Hyoscyamine—pancreatitis	0.002	0.00741	CcSEcCtD
Mirtazapine—Hyponatraemia—Hyoscyamine—pancreatitis	0.00196	0.00729	CcSEcCtD
Mirtazapine—Osteoarthritis—Hyoscyamine—pancreatitis	0.00196	0.00726	CcSEcCtD
Mirtazapine—Dry mouth—Propantheline—pancreatitis	0.00192	0.00712	CcSEcCtD
Mirtazapine—Psychotic disorder—Hyoscyamine—pancreatitis	0.00191	0.00709	CcSEcCtD
Mirtazapine—Confusional state—Propantheline—pancreatitis	0.00189	0.00703	CcSEcCtD
Mirtazapine—Urinary retention—Hyoscyamine—pancreatitis	0.00186	0.00691	CcSEcCtD
Mirtazapine—Ataxia—Hyoscyamine—pancreatitis	0.00184	0.00683	CcSEcCtD
Mirtazapine—Tachycardia—Propantheline—pancreatitis	0.00183	0.00681	CcSEcCtD
Mirtazapine—Dehydration—Hyoscyamine—pancreatitis	0.00182	0.00676	CcSEcCtD
Mirtazapine—Dry skin—Hyoscyamine—pancreatitis	0.00179	0.00666	CcSEcCtD
Mirtazapine—Abdominal distension—Hyoscyamine—pancreatitis	0.0017	0.00632	CcSEcCtD
Mirtazapine—Insomnia—Propantheline—pancreatitis	0.0017	0.00631	CcSEcCtD
Mirtazapine—Somnolence—Propantheline—pancreatitis	0.00167	0.0062	CcSEcCtD
Mirtazapine—Angina pectoris—Hyoscyamine—pancreatitis	0.00165	0.00612	CcSEcCtD
Mirtazapine—Constipation—Propantheline—pancreatitis	0.00161	0.00596	CcSEcCtD
Mirtazapine—Dysuria—Hyoscyamine—pancreatitis	0.00158	0.00587	CcSEcCtD
Mirtazapine—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00156	0.00578	CcSEcCtD
Mirtazapine—Feeling abnormal—Propantheline—pancreatitis	0.00155	0.00575	CcSEcCtD
Mirtazapine—Drowsiness—Hyoscyamine—pancreatitis	0.00151	0.0056	CcSEcCtD
Mirtazapine—Urticaria—Propantheline—pancreatitis	0.00149	0.00554	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.00149	0.00552	CcSEcCtD
Mirtazapine—Myocardial infarction—Hyoscyamine—pancreatitis	0.00148	0.00549	CcSEcCtD
Mirtazapine—Conjunctivitis—Hyoscyamine—pancreatitis	0.00147	0.00544	CcSEcCtD
Mirtazapine—Sweating—Hyoscyamine—pancreatitis	0.00145	0.00537	CcSEcCtD
Mirtazapine—Hypersensitivity—Propantheline—pancreatitis	0.00138	0.00514	CcSEcCtD
Mirtazapine—Bradycardia—Hyoscyamine—pancreatitis	0.00138	0.00512	CcSEcCtD
Mirtazapine—Asthenia—Propantheline—pancreatitis	0.00135	0.005	CcSEcCtD
Mirtazapine—Hallucination—Hyoscyamine—pancreatitis	0.00135	0.005	CcSEcCtD
Mirtazapine—Dizziness—Propantheline—pancreatitis	0.00124	0.00461	CcSEcCtD
Mirtazapine—Arrhythmia—Hyoscyamine—pancreatitis	0.00121	0.00449	CcSEcCtD
Mirtazapine—Vomiting—Propantheline—pancreatitis	0.00119	0.00443	CcSEcCtD
Mirtazapine—Mental disorder—Hyoscyamine—pancreatitis	0.00119	0.0044	CcSEcCtD
Mirtazapine—Rash—Propantheline—pancreatitis	0.00118	0.0044	CcSEcCtD
Mirtazapine—Dermatitis—Propantheline—pancreatitis	0.00118	0.00439	CcSEcCtD
Mirtazapine—Headache—Propantheline—pancreatitis	0.00118	0.00437	CcSEcCtD
Mirtazapine—Tension—Hyoscyamine—pancreatitis	0.00116	0.00429	CcSEcCtD
Mirtazapine—Dysgeusia—Hyoscyamine—pancreatitis	0.00115	0.00428	CcSEcCtD
Mirtazapine—Nervousness—Hyoscyamine—pancreatitis	0.00114	0.00425	CcSEcCtD
Mirtazapine—Nausea—Propantheline—pancreatitis	0.00112	0.00414	CcSEcCtD
Mirtazapine—Agitation—Hyoscyamine—pancreatitis	0.00108	0.00402	CcSEcCtD
Mirtazapine—Vertigo—Hyoscyamine—pancreatitis	0.00106	0.00393	CcSEcCtD
Mirtazapine—Syncope—Hyoscyamine—pancreatitis	0.00106	0.00392	CcSEcCtD
Mirtazapine—Palpitations—Hyoscyamine—pancreatitis	0.00104	0.00387	CcSEcCtD
Mirtazapine—Loss of consciousness—Hyoscyamine—pancreatitis	0.00104	0.00385	CcSEcCtD
Mirtazapine—Convulsion—Hyoscyamine—pancreatitis	0.00102	0.00379	CcSEcCtD
Mirtazapine—Chest pain—Hyoscyamine—pancreatitis	0.001	0.00372	CcSEcCtD
Mirtazapine—Anxiety—Hyoscyamine—pancreatitis	0.001	0.00371	CcSEcCtD
Mirtazapine—Dry mouth—Hyoscyamine—pancreatitis	0.000981	0.00364	CcSEcCtD
Mirtazapine—Confusional state—Hyoscyamine—pancreatitis	0.00097	0.0036	CcSEcCtD
Mirtazapine—Oedema—Hyoscyamine—pancreatitis	0.000962	0.00357	CcSEcCtD
Mirtazapine—Shock—Hyoscyamine—pancreatitis	0.000946	0.00351	CcSEcCtD
Mirtazapine—Tachycardia—Hyoscyamine—pancreatitis	0.000939	0.00348	CcSEcCtD
Mirtazapine—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00093	0.00345	CcSEcCtD
Mirtazapine—Hypotension—Hyoscyamine—pancreatitis	0.000899	0.00334	CcSEcCtD
Mirtazapine—Insomnia—Hyoscyamine—pancreatitis	0.00087	0.00323	CcSEcCtD
Mirtazapine—Dyspnoea—Hyoscyamine—pancreatitis	0.000857	0.00318	CcSEcCtD
Mirtazapine—Somnolence—Hyoscyamine—pancreatitis	0.000855	0.00317	CcSEcCtD
Mirtazapine—Dyspepsia—Hyoscyamine—pancreatitis	0.000847	0.00314	CcSEcCtD
Mirtazapine—Fatigue—Hyoscyamine—pancreatitis	0.000829	0.00308	CcSEcCtD
Mirtazapine—Constipation—Hyoscyamine—pancreatitis	0.000822	0.00305	CcSEcCtD
Mirtazapine—Pain—Hyoscyamine—pancreatitis	0.000822	0.00305	CcSEcCtD
Mirtazapine—Feeling abnormal—Hyoscyamine—pancreatitis	0.000793	0.00294	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000786	0.00292	CcSEcCtD
Mirtazapine—Urticaria—Hyoscyamine—pancreatitis	0.000764	0.00284	CcSEcCtD
Mirtazapine—Body temperature increased—Hyoscyamine—pancreatitis	0.00076	0.00282	CcSEcCtD
Mirtazapine—Abdominal pain—Hyoscyamine—pancreatitis	0.00076	0.00282	CcSEcCtD
Mirtazapine—Hypersensitivity—Hyoscyamine—pancreatitis	0.000709	0.00263	CcSEcCtD
Mirtazapine—Asthenia—Hyoscyamine—pancreatitis	0.00069	0.00256	CcSEcCtD
Mirtazapine—Pruritus—Hyoscyamine—pancreatitis	0.00068	0.00253	CcSEcCtD
Mirtazapine—Diarrhoea—Hyoscyamine—pancreatitis	0.000658	0.00244	CcSEcCtD
Mirtazapine—Dizziness—Hyoscyamine—pancreatitis	0.000636	0.00236	CcSEcCtD
Mirtazapine—Vomiting—Hyoscyamine—pancreatitis	0.000612	0.00227	CcSEcCtD
Mirtazapine—Rash—Hyoscyamine—pancreatitis	0.000606	0.00225	CcSEcCtD
Mirtazapine—Dermatitis—Hyoscyamine—pancreatitis	0.000606	0.00225	CcSEcCtD
Mirtazapine—Headache—Hyoscyamine—pancreatitis	0.000603	0.00224	CcSEcCtD
Mirtazapine—Nausea—Hyoscyamine—pancreatitis	0.000571	0.00212	CcSEcCtD
Mirtazapine—Epinastine—HTR2A—pancreatitis	0.000218	0.633	CrCbGaD
Mirtazapine—Mianserin—HTR2A—pancreatitis	0.000126	0.366	CrCbGaD
Mirtazapine—ADRA2C—Signaling Pathways—LEP—pancreatitis	1.28e-05	5.72e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCL2—pancreatitis	1.28e-05	5.7e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MDM2—pancreatitis	1.27e-05	5.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL5—pancreatitis	1.27e-05	5.67e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—KRAS—pancreatitis	1.27e-05	5.66e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SPP1—pancreatitis	1.26e-05	5.65e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—CXCL8—pancreatitis	1.26e-05	5.63e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HTR2A—pancreatitis	1.25e-05	5.58e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—NRAS—pancreatitis	1.25e-05	5.58e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—LPL—pancreatitis	1.24e-05	5.54e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.24e-05	5.52e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GCG—pancreatitis	1.23e-05	5.51e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HTR2A—pancreatitis	1.23e-05	5.48e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GCG—pancreatitis	1.22e-05	5.46e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—NRAS—pancreatitis	1.22e-05	5.46e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MDM2—pancreatitis	1.21e-05	5.43e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.21e-05	5.4e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CXCL8—pancreatitis	1.2e-05	5.39e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HTR2A—pancreatitis	1.2e-05	5.38e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PLA2G1B—pancreatitis	1.2e-05	5.38e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—ALB—pancreatitis	1.2e-05	5.36e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—HRAS—pancreatitis	1.2e-05	5.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—HRAS—pancreatitis	1.2e-05	5.35e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—NRAS—pancreatitis	1.19e-05	5.34e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—NRAS—pancreatitis	1.19e-05	5.31e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CXCL8—pancreatitis	1.19e-05	5.3e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—INS—pancreatitis	1.18e-05	5.28e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—KRAS—pancreatitis	1.18e-05	5.27e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—HRAS—pancreatitis	1.18e-05	5.27e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—LPL—pancreatitis	1.18e-05	5.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SPP1—pancreatitis	1.17e-05	5.25e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—CXCL8—pancreatitis	1.17e-05	5.23e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCL2—pancreatitis	1.16e-05	5.2e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—A2M—pancreatitis	1.16e-05	5.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—LEP—pancreatitis	1.16e-05	5.19e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MDM2—pancreatitis	1.16e-05	5.18e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—INS—pancreatitis	1.16e-05	5.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—NRAS—pancreatitis	1.15e-05	5.16e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CASP3—pancreatitis	1.15e-05	5.16e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—pancreatitis	1.15e-05	5.12e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—LEP—pancreatitis	1.14e-05	5.11e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—LEP—pancreatitis	1.14e-05	5.1e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCL2—pancreatitis	1.14e-05	5.08e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CXCL8—pancreatitis	1.14e-05	5.08e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CASP3—pancreatitis	1.14e-05	5.08e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—INS—pancreatitis	1.13e-05	5.05e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—HRAS—pancreatitis	1.13e-05	5.04e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—pancreatitis	1.13e-05	5.04e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—INS—pancreatitis	1.12e-05	5.03e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—LEP—pancreatitis	1.12e-05	5e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HTR2A—pancreatitis	1.12e-05	5e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCL2—pancreatitis	1.11e-05	4.97e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCL2—pancreatitis	1.11e-05	4.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—INS—pancreatitis	1.09e-05	4.89e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CASP3—pancreatitis	1.09e-05	4.86e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CXCL8—pancreatitis	1.08e-05	4.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PPARG—pancreatitis	1.08e-05	4.84e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—pancreatitis	1.08e-05	4.83e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MDM2—pancreatitis	1.08e-05	4.82e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—HRAS—pancreatitis	1.08e-05	4.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCL2—pancreatitis	1.08e-05	4.81e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—KRAS—pancreatitis	1.07e-05	4.8e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALDH2—pancreatitis	1.06e-05	4.75e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—INS—pancreatitis	1.06e-05	4.75e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.06e-05	4.72e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—KRAS—pancreatitis	1.05e-05	4.7e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTGS2—pancreatitis	1.05e-05	4.69e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—NRAS—pancreatitis	1.05e-05	4.69e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GCG—pancreatitis	1.04e-05	4.66e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—LEP—pancreatitis	1.04e-05	4.65e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CASP3—pancreatitis	1.04e-05	4.64e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—NRAS—pancreatitis	1.03e-05	4.61e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—pancreatitis	1.03e-05	4.61e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—NRAS—pancreatitis	1.03e-05	4.6e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—KRAS—pancreatitis	1.03e-05	4.59e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—KRAS—pancreatitis	1.02e-05	4.57e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—NRAS—pancreatitis	1.01e-05	4.51e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CXCL8—pancreatitis	1.01e-05	4.51e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—HRAS—pancreatitis	1e-05	4.48e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—KRAS—pancreatitis	9.94e-06	4.44e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—INS—pancreatitis	9.92e-06	4.44e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MDM2—pancreatitis	9.83e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—INS—pancreatitis	9.76e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCL2—pancreatitis	9.76e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—INS—pancreatitis	9.74e-06	4.35e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ALB—pancreatitis	9.74e-06	4.35e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NRAS—pancreatitis	9.66e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—LPL—pancreatitis	9.66e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CASP3—pancreatitis	9.65e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MDM2—pancreatitis	9.61e-06	4.3e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCL2—pancreatitis	9.6e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—pancreatitis	9.59e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCL2—pancreatitis	9.58e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—LPL—pancreatitis	9.58e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—INS—pancreatitis	9.56e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—NRAS—pancreatitis	9.51e-06	4.25e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCL2—pancreatitis	9.4e-06	4.2e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MDM2—pancreatitis	9.4e-06	4.2e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—NRAS—pancreatitis	9.38e-06	4.19e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MDM2—pancreatitis	9.35e-06	4.18e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCL8—pancreatitis	9.19e-06	4.11e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HRAS—pancreatitis	9.13e-06	4.08e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NRAS—pancreatitis	9.11e-06	4.07e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MDM2—pancreatitis	9.09e-06	4.07e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—KRAS—pancreatitis	9.02e-06	4.03e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL8—pancreatitis	8.99e-06	4.02e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TGFB1—pancreatitis	8.98e-06	4.02e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HRAS—pancreatitis	8.93e-06	3.99e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—INS—pancreatitis	8.88e-06	3.97e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—KRAS—pancreatitis	8.87e-06	3.97e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—KRAS—pancreatitis	8.85e-06	3.96e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TGFB1—pancreatitis	8.84e-06	3.95e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CASP3—pancreatitis	8.79e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL8—pancreatitis	8.79e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL8—pancreatitis	8.74e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—pancreatitis	8.74e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL2—pancreatitis	8.74e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HRAS—pancreatitis	8.73e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NRAS—pancreatitis	8.69e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—KRAS—pancreatitis	8.69e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HRAS—pancreatitis	8.69e-06	3.88e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CASP3—pancreatitis	8.6e-06	3.85e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARG—pancreatitis	8.59e-06	3.84e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—pancreatitis	8.55e-06	3.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—pancreatitis	8.52e-06	3.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL8—pancreatitis	8.5e-06	3.8e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TGFB1—pancreatitis	8.46e-06	3.78e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HRAS—pancreatitis	8.45e-06	3.78e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—INS—pancreatitis	8.43e-06	3.77e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CASP3—pancreatitis	8.41e-06	3.76e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CASP3—pancreatitis	8.37e-06	3.74e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—pancreatitis	8.36e-06	3.74e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KRAS—pancreatitis	8.32e-06	3.72e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—pancreatitis	8.31e-06	3.72e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MDM2—pancreatitis	8.25e-06	3.69e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KRAS—pancreatitis	8.19e-06	3.66e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—LPL—pancreatitis	8.19e-06	3.66e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CASP3—pancreatitis	8.14e-06	3.64e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MDM2—pancreatitis	8.12e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MDM2—pancreatitis	8.1e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NRAS—pancreatitis	8.09e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—pancreatitis	8.09e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TGFB1—pancreatitis	8.08e-06	3.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—KRAS—pancreatitis	8.07e-06	3.61e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GCG—pancreatitis	8.05e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MDM2—pancreatitis	7.95e-06	3.56e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KRAS—pancreatitis	7.84e-06	3.5e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—pancreatitis	7.73e-06	3.46e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—pancreatitis	7.72e-06	3.45e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—pancreatitis	7.67e-06	3.43e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—pancreatitis	7.59e-06	3.39e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—pancreatitis	7.58e-06	3.39e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—pancreatitis	7.54e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—pancreatitis	7.53e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFB1—pancreatitis	7.52e-06	3.36e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—pancreatitis	7.48e-06	3.35e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—pancreatitis	7.43e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MDM2—pancreatitis	7.39e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—pancreatitis	7.39e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—pancreatitis	7.38e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NRAS—pancreatitis	7.37e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—pancreatitis	7.34e-06	3.28e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—pancreatitis	7.27e-06	3.25e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—pancreatitis	7.25e-06	3.24e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—pancreatitis	7.22e-06	3.23e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—pancreatitis	7.21e-06	3.22e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—pancreatitis	7.2e-06	3.22e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—pancreatitis	7.11e-06	3.18e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—pancreatitis	7.07e-06	3.16e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—pancreatitis	7.07e-06	3.16e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—pancreatitis	7.06e-06	3.15e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—pancreatitis	7.05e-06	3.15e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—pancreatitis	7.01e-06	3.14e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—pancreatitis	6.99e-06	3.13e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—pancreatitis	6.96e-06	3.11e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—pancreatitis	6.96e-06	3.11e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—INS—pancreatitis	6.92e-06	3.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—pancreatitis	6.91e-06	3.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—pancreatitis	6.86e-06	3.07e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—INS—pancreatitis	6.86e-06	3.07e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—pancreatitis	6.85e-06	3.06e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—pancreatitis	6.82e-06	3.05e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—pancreatitis	6.77e-06	3.03e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—pancreatitis	6.76e-06	3.02e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—pancreatitis	6.7e-06	3e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—pancreatitis	6.66e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—pancreatitis	6.66e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—pancreatitis	6.61e-06	2.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—pancreatitis	6.57e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—pancreatitis	6.55e-06	2.93e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—pancreatitis	6.52e-06	2.91e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—pancreatitis	6.38e-06	2.85e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—pancreatitis	6.36e-06	2.84e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—pancreatitis	6.34e-06	2.84e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—pancreatitis	6.34e-06	2.84e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—pancreatitis	6.34e-06	2.83e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—LPL—pancreatitis	6.32e-06	2.82e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—pancreatitis	6.29e-06	2.81e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—pancreatitis	6.21e-06	2.77e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—pancreatitis	6.19e-06	2.77e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—pancreatitis	6.09e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—pancreatitis	6.09e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—pancreatitis	6.08e-06	2.72e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—pancreatitis	6.07e-06	2.71e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—pancreatitis	6.04e-06	2.7e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—pancreatitis	5.98e-06	2.67e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—pancreatitis	5.96e-06	2.67e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—pancreatitis	5.92e-06	2.65e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—pancreatitis	5.87e-06	2.63e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—INS—pancreatitis	5.86e-06	2.62e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—pancreatitis	5.75e-06	2.57e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—pancreatitis	5.66e-06	2.53e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—pancreatitis	5.66e-06	2.53e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—pancreatitis	5.65e-06	2.53e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—pancreatitis	5.55e-06	2.48e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—pancreatitis	5.54e-06	2.48e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—pancreatitis	5.54e-06	2.48e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—pancreatitis	5.5e-06	2.46e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—pancreatitis	5.39e-06	2.41e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—pancreatitis	5.37e-06	2.4e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—pancreatitis	5.33e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—pancreatitis	5.27e-06	2.36e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—pancreatitis	5.24e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—pancreatitis	5.23e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—pancreatitis	5.16e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—pancreatitis	5.16e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—pancreatitis	5.15e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—pancreatitis	5.13e-06	2.3e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—pancreatitis	5.13e-06	2.29e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—pancreatitis	5.05e-06	2.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—pancreatitis	4.99e-06	2.23e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—pancreatitis	4.94e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—pancreatitis	4.91e-06	2.2e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—pancreatitis	4.78e-06	2.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—pancreatitis	4.77e-06	2.13e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—pancreatitis	4.7e-06	2.1e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—pancreatitis	4.61e-06	2.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—pancreatitis	4.53e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—INS—pancreatitis	4.52e-06	2.02e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—pancreatitis	4.46e-06	1.99e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—pancreatitis	4.45e-06	1.99e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—pancreatitis	4.36e-06	1.95e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—pancreatitis	4.33e-06	1.94e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—pancreatitis	4.26e-06	1.91e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—pancreatitis	4.26e-06	1.9e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—pancreatitis	4.18e-06	1.87e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—pancreatitis	4.15e-06	1.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—pancreatitis	4.05e-06	1.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—pancreatitis	3.88e-06	1.73e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—pancreatitis	3.63e-06	1.62e-05	CbGpPWpGaD
